Alveolar Ridge Preservation After Tooth Extraction (CRES-PRES)

July 28, 2025 updated by: Mr. Claudio Stacchi, DDS, MSc, International Piezosurgery Academy

Alveolar Ridge Preservation With Several Techniques: a Multicenter Observational Longitudinal Study

Post-extractive alveolar ridge remodeling represents a physiological phenomenon that may hamper successive implant insertion. Several techniques have been proposed without any significant difference of efficacy among them. Moreover several research protocols of analysis have been proposed, including histomorphometric, radiological, clinical analysis.

The purpose of the present study is to test different alveolar ridge preservation techniques using histomorphometric and optical scanning analysis.

Study Overview

Detailed Description

Primary objective The primary objective of the study is to clinically compare the effect on the preservation of the alveolar ridge using different techniques (dental roots in association with platelet rich fibrin, BARP (Biologically-oriented Alveolar Ridge Preservation), Ice Cream Cone Technique and unassisted socket healing).

Secondary objective The secondary objective is the collection of histological and histomorphometric data that allow to evaluate the quality and quantity of newly formed bone.

Study design Multicenter observational study of a prospective non-profit case-control.

List of centers involved in addition to our facility:

- University of Porto, Faculty of Dentistry, Specialization in Periodontology and Implantology.

Study population The study will be conducted in an outpatient hospital setting.

Number of patients to be enrolled to compare autogenous tooth roots (TR) and ice cream cone technique (ICCT): 32 patients among all the centers involved, of which 16 patients in the University of Porto and 16 patients in University of Trieste center including dropouts.

Number of patients to be enrolled to compare BARP and unassisted socket healing: 30 patients in the University of Trieste including dropouts.

Enrollment procedure All patients who meet the inclusion and exclusion criteria will be enrolled in the study following the administration of the Information Sheet and the acquisition of informed consent.

The choice of the alveolar ridge preservation protocol will be motivated by the clinicians experience and the patients preference among those currently validated (ice-cream cone technique, tooth root, etc.).

Autogenous tooth roots: under local anesthesia, a trapezoidal mucoperiosteal flap, extended to adjacent teeth mesially and distally, will be raised to expose the defect and remove granulation tissue. The dental root graft will be obtained by sectioning the extracted tooth at the cementoenamel junction and then separating the root longitudinally to fully expose the pulp chamber using a tungsten carbide bur with irrigation. The specimen will then be thoroughly cleaned using manual curettes on the external surface, while the removal of residual pulp tissue and/or root canal filling material will be performed using a tungsten carbide bur with irrigation. The tooth root specimen will be resized to fit the height and width of the post-extraction site to be regenerated and fixed using one to two titanium osteosynthesis screws. A blood sample will then be collected in two sterile glass-lined plastic tubes and processed to produce a platelet rich fibrin membrane. The blood sample will be centrifuged (2700 rpm for 12 minutes). The platelet rich fibrin will then be removed from the tubes and placed on the surgical site. Periosteal releasing incisions will be made to advance the mucoperiosteal flap, which will be repositioned coronally and secured with horizontal mattress sutures and single stitches to ensure a submerged healing condition.

Ice Cream Cone technique: under local anesthesia, the compromised tooth will be extracted atraumatically without raising a flap. A resorbable collagen membrane will be shaped into a cone and inserted into the socket, into which the xenograft will be placed; mattress sutures will then be placed.

BARP: under local anesthesia, the compromised tooth will be extracted atraumatically without raising a flap. After granulation tissue removal, the socket will be filled with a collagen sponge (deep collagen layer) up to 4 to 5 mm from the most coronal extensions of the buccal crest to create a support for the intra-alveolar graft. A bovine derived xenograft will be placed on top of the collagen sponge to fill the coronal part of the socket, avoiding overfilling (graft layer). Socket sealing will be performed with a new layer of collagen sponge that will be placed over the exposed portion of the graft layer and firmly held by sutures.

For all patients, after 26 weeks of healing, a mucoperiosteal flap will be raised to expose the target site and a titanium implant will be inserted. During this phase, using a core drill to prepare the implant site, it will also be functional to obtain a bone sample that will be subsequently analyzed.

Study Outcomes

The primary endpoint is the width of the alveolar ridge, which will be assessed in two stages:

  • T0: initial condition of the alveolar ridge, measured before performing surgery;
  • T1: final condition of the alveolar ridge, measured before implant insertion at 26 weeks of healing from surgery.

The primary endpoint will be classified as follows. The secondary endpoints are represented by histomorphometric variables: newly formed mineralized tissue (New bone/Total volume), graft residues (RG/TV), newly formed non-mineralized tissue (Nonmineralised tissue/Total volume), total mineralized tissue that will be assessed at twenty-six weeks of healing (Mineralised tissue/total volume) evaluated as means and standard deviations and with χ2 test.

The primary endpoint will then be assessed in relation to complications and adverse events, such as:

  • Soft tissue dehiscence;
  • Graft exposure;
  • Graft loss;
  • Wound infections.

The width of the alveolar ridge will be measured linearly and volumetrically, using digital scans processed by a 3D scanning software (Geomagic Control X, 3D System, Morrisville, USA) at the University of Trieste.

The data collected at follow-up and the outcome data are based on a clinical evaluation, considering the possible presence of complications and adverse events.

The histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and the origin of the biopsy. The biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). The samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then processed for histological and histomorphometric evaluation at the Bone Lab, University of Trieste. After this, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.

Collected data variables and sources

The following variables will be collected for each enrolled patient/participant:

  • Width of the alveolar ridge;
  • Newly formed mineralized tissue, graft residues, non-mineralized newly formed tissue, total mineralized tissue.

Histological and histomorphometric analysis of all samples will be performed by one of the authors, blinded to the study design and biopsy origin. Biopsies, left inside the core drills to maintain the orientation of the bone core, will be rinsed with a cold 5% glucose solution to remove blood residues while maintaining the correct osmolarity (278 mOsm/L). Samples will then be fixed for 3 days in a 10% buffered formalin solution at pH 7.2 and then dehydrated in ascending series of alcohol rinses. After 5 days of preinfiltration in a 50% resin/alcohol solution, biopsies will be removed from the core drills and sample infiltration will be completed with methacrylate resin. After 12 days of polymerization, the samples will be cut along their longitudinal axis using a high-precision silicon carbide disc at 50 μm and then finished under running water with a series of polishing discs at approximately 30 ± 10 μm. They will then be mounted on slides and stained with acid fuchsin, toluidine blue and Von Kossa.

Following histological and histomorphometric analyses, the samples will be delivered to specialized and authorized companies for disposal, according to current legislation.

Statistical plan The statistical analysis will be performed by means of a computerized statistical package (SigmaStat 3.5, SPSS Inc., Germany). The data will be expressed as mean ± standard deviation and median (interquartile range), respectively, for parametric and non-parametric values.

Sample size calculation The aim of the study is to clinically compare different alveolar ridge preservation techniques.

Considering the outcomes of previously published studies, it was calculated that will be necessary to recruit 15 patients for each group to obtain a statistically significant result through a comparison between subpopulations with a statistical power of 95% and a significance of 0.05.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Trieste, Italy, 34100
        • University of Trieste, Departmen of Medicine, Surgery, Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients needing for tooth extraction and possible implant insertion meeting inclusion and exclusion criteria were eligible

Description

Inclusion Criteria:

  • Age between 18 and 80 years;
  • Single-rooted tooth with indication for extraction and presenting adjacent teeth;
  • Presence of type II defect;
  • Sufficient bone height of the extraction site for the insertion of a standard implant (≥8.5 mm);
  • Healthy oral mucosa with at least 3 mm of keratinized tissue;
  • American Society of Anesthesiologists 3;
  • Periodontal health or stability;
  • Signature of informed consent.

Exclusion Criteria:

  • Presence of general contraindications for oral surgery;
  • Presence of inflammatory and autoimmune diseases;
  • Uncontrolled diabetes (HbA1c 7%);
  • History of tumors requiring chemotherapy or radiotherapy in the last 5 years;
  • Previous therapy with bisphosphonates or high-dose corticosteroid therapy;
  • Smoking (10 cigarettes/day);
  • Allergy to bovine collagen;
  • Pregnancy or breastfeeding;
  • Lack of compliance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
BARP
collagen-bonegraft-collagen
deep layers of collagen, medium-superficial heterologous bone graft, superficial collagen layer
Other Names:
  • Biologically-oriented Alveolar Ridge Preservation
unassisted
unassisted healing
tooth extraction without grafting procedure.
Tooth root
tooth root and PRF
Autogenous roots derived from the extracted hopeless tooth and stabilized with osteosynthesis screws to reconstruct the missing buccal wall of the socket. The defect was then filled with PRF.
Ice Cream Cone Technique
bonegraft and collagen membrane
xenogeneic granules and a resorbable collagen membrane

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
alveolar volume
Time Frame: 6 months post-extractive
optical scanning comparison
6 months post-extractive

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
histomorphometric analysis
Time Frame: 6 months post-extraction
bone volume/total volume
6 months post-extraction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claudio Stacchi, Dr., University of Trieste, Department of Medicine, Surgery and Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2024

Primary Completion (Actual)

December 6, 2024

Study Completion (Estimated)

January 31, 2026

Study Registration Dates

First Submitted

August 6, 2024

First Submitted That Met QC Criteria

August 6, 2024

First Posted (Actual)

August 9, 2024

Study Record Updates

Last Update Posted (Actual)

July 31, 2025

Last Update Submitted That Met QC Criteria

July 28, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Bone Loss

Clinical Trials on BARP

Subscribe